White label ELPA - ClinicalTrials.eu

Study on the Safety and Effectiveness of Acasunlimab and Pembrolizumab for Patients with Recurrent Non-Small Cell Lung Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
- Acasunlimab
- Pembrolizumab
+1
Study on Testosterone Undecanoate for Muscle Strength and Mass in Men with Obesity and Low Testosterone Undergoing Bariatric Surgery

Not recruiting

3 1 1
Investigated diseases:
- Hypogonadism male
- Obesity
Investigated drugs:
- Testosterone Undecanoate
Comparison of Post-Transplant Cyclophosphamide versus Anti-T Lymphocyte Immunoglobulin for Prevention of Graft versus Host Disease in Patients Receiving Unrelated Donor Transplantation

Not recruiting

3 1 1 1
Investigated diseases:
- Acute graft versus host disease
- Graft versus host disease
Investigated drugs:
Study on Long-Acting Cabotegravir and Lenacapavir for HIV Patients: Evaluating Dual Antiretroviral Therapy

Not recruiting

3 1 1 1
Investigated diseases:
- HIV infection
Investigated drugs:
Study on Masitinib for Patients with Severe Mast Cell Activation Syndrome Unresponsive to Treatment

Not recruiting

2 1
Investigated diseases:
- Mast cell activation syndrome
Investigated drugs:
- Masitinib
Study on Treating Acute Gout Attacks with Prednisolone and Colchicine for Primary Care Patients

Not recruiting

3 1 1
Investigated diseases:
- Gout
Investigated drugs:
- Colchicine
- Prednisolone
Study of belantamab mafodotin, bortezomib and dexamethasone combination in adults with relapsed or refractory multiple myeloma who received at least one prior therapy

Not recruiting

2 1 1 1
Investigated diseases:
- Plasma cell myeloma refractory
Investigated drugs:
Study on the Effects of Tamuzimod in Patients with Moderate to Severe Ulcerative Colitis

Not recruiting

2 1
Investigated drugs:
- Tamuzimod Acetate
+2
Study Comparing Retatrutide and Tirzepatide for Weight Loss in Adults with Obesity

Not recruiting

3 1 1
Investigated diseases:
- Obesity
Investigated drugs:
- Ly3437943 Sodium
- Tirzepatide
Study of Durvalumab, Tremelimumab, and Capecitabine for Patients with Biliary Tract Cancer in an Adjuvant Setting

Not recruiting

2 1 1 1
Investigated diseases:
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies